Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
In this webinar, the speakers will review medication information resources and present an approach to administration of medications when dialyzability data are limited in the hemodialysis and peritoneal dialysis populations.
Please join us and our leading expert, Kristen Nowak, PhD, MPH, as she showcases her laboratory findings about the complex relationship between diet, obesity and the role that they play in disease progression.
Please join us and our leading expert, Kristen Nowak, PhD, MPH, as she showcases her laboratory findings about the complex relationship between diet, obesity and the role that they play in disease progression.
This webinar will discuss the impact of pain in patients with ADPKD and the applications of a new tool in standardizing assessment of pain.
This webinar will discuss a diagnostic work up for ADPKD and walk through a diagnostic algorithm including a differential diagnosis for cystic kidney disease.
This webinar will discuss a diagnostic work up for ADPKD and walk through a diagnostic algorithm including a differential diagnosis for cystic kidney disease.
This webinar highlights Chef JJ's kidney healthy pumpkin pancake and berry compote recipe along with a discussion on the deeper dietary details from Misty Nason.
In this presentation, the complexities of genetic testing in ADPKD, recommendations on when genetic testing is appropriate and indicated, and the various types of molecular genetic tests available will be discussed.
Dr. Workeneh, a double Board-certified nephrologist and internist, and professor will discuss the pathophysiology and management of HTN in patients with ADPKD, CKD, and the GP.
Autosomal Dominant Polycystic Kidney Disease (ADPKD), an inherited progressive kidney disease, is the fourth leading cause of kidney failure in the US. ADPKD has a spectrum of clinical and imaging features that have direct prognostic implications1. Total kidney volume (TKV), adjusted for height and age, has been shown to be the best predictor of kidney function decline; this forms the basis for the Mayo Clinic Imaging Classification (MCIC) of the severity grade of ADPKD1. Radiology’s central role in ADPKD is to aid in the imaging-based diagnosis, prognostication, and monitoring for disease progression.
Join us for our panel discussion, where experts discuss their passion for ADPKD and IgAN and how the entire kidney community can rally around Rare Disease Day to raise awareness about these rare kidney diseases.
In this presentation, we will discuss the important role of imaging in diagnosis and prognosis of ADPKD, including measuring TKV, looking at complications and more.
